ArticleCancer medicine2026
Daily Symptom Home Monitoring Decreases Hospital Readmissions in Children and Young Adults With Acute Lymphoblastic Leukemia.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveAdvancements in treatment of Acute Lymphoblastic Leukemia have led to high overall survival rates but are accompanied by significant treatment-related morbidity and mortality. We aimed to determine whether daily symptom home monitoring paired with targeted nursing intervention decreased readmission rates in newly diagnosed pediatric and adolescent young adults with Acute Lymphoblastic Leukemia at a single large pediatric oncology center.
methodsA daily symptom home monitoring survey was texted to families' cellular phones of patients undergoing the initial chemotherapy block (Induction) for Acute Lymphoblastic Leukemia, and responses were monitored and intervened on by nurse clinicians. Control families did not receive daily symptom home monitoring surveys. Readmission rates, total days at home, patient symptoms, and quality of life measures were assessed in both control and participant groups.
resultsEighteen control patients and 58 participants were enrolled. Among the patients in the intervention group, 48 patients (82.8%) were not readmitted vs. 10 patients (55.6%) in the control group (p = 0.028). Patients in the intervention group spent 18.7 days at home versus patients in the control group spent 16.4 days at home (p = 0.112). Patient demographics and caregiver distress measures did not significantly differ between the two groups.
conclusionsImplementation of a daily symptom home monitoring texted survey aimed at identifying and responding to patients' morbidities allowed for timely intervention and significantly decreased readmission rates without worsening caregiver distress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.